We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Neoantigens Could Be Key to Unlocking a New Generation of Immunotherapies

News   Oct 12, 2020 | Original story from the Parker Institute for Cancer Immunotherapy

 
Neoantigens Could Be Key to Unlocking a New Generation of Immunotherapies

International neoantigen initiative Tumor Neoantigen Selection Alliance (TESLA) identifies parameters for cancer vaccine or cell therapy advancement. Credit: Parker Institute for Cancer Immunotherapy

 
 
Advertisement
 

RELATED ARTICLES

Anemone Produce Toxins That Have Pharmacological Potential

News

Researchers based in Brazil and the United States have completed the first-ever mapping exercise to profile the toxins produced by tube-dwelling anemones, or cerianthids, a family of marine animals. The analysis revealed that the toxins that can act on the nervous system, cardiovascular system, and cell walls, among other functions, paving the way to the discovery of novel medications.

READ MORE

Why Are Some People Infected With COVID-19 Asymptomatic?

News

A team of researchers from Aarhus University and Aarhus University Hospital in Denmark set out to investigate how important immune cells react to the SARS-CoV-2 virus.

READ MORE

Scientists Map the Genome of Agricultural Monsters

News

An associate professor in UC’s College of Arts and Sciences contributed to genetic studies of New World screwworms that feed on livestock and thrips, tiny insects that can transmit viruses to tomatoes and other plants.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE